Cargando...

Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.

The MICs of trovafloxacin, ciprofloxacin, ofloxacin, and sparfloxacin at which 90% of isolates are inhibited for 55 isolates of pneumococci were 0.125, 1, 4, and 0.5 microgram/ml, respectively. Resistant mutants of two susceptible isolates were selected in a stepwise fashion on agar containing cipro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gootz, T D, Zaniewski, R, Haskell, S, Schmieder, B, Tankovic, J, Girard, D, Courvalin, P, Polzer, R J
Formato: Artigo
Idioma:Inglês
Publicado: 1996
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC163605/
https://ncbi.nlm.nih.gov/pubmed/9124824
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!